Cardiology · Arrhythmias
The facts most likely to be tested
Ventricular fibrillation is a pulseless rhythm characterized by chaotic, irregular electrical activity with no identifiable P waves, QRS complexes, or T waves.
Defibrillation is the definitive, immediate treatment and must be performed as soon as a defibrillator is available.
Cardiopulmonary resuscitation (CPR) must be initiated immediately and continued without interruption while the defibrillator is charging.
Epinephrine is the first-line pharmacologic agent administered during Advanced Cardiac Life Support (ACLS) protocols for refractory ventricular fibrillation.
Amiodarone or lidocaine are the antiarrhythmic agents of choice for patients who remain in ventricular fibrillation after initial defibrillation and epinephrine administration.
Coronary artery disease and myocardial infarction are the most common underlying etiologies of ventricular fibrillation in adults.
Implantable cardioverter-defibrillator (ICD) placement is the indicated long-term management for patients who survive an episode of ventricular fibrillation not caused by a reversible trigger.
Vignette unlocked
A 62-year-old male with a history of hypertension and prior myocardial infarction is found unresponsive in the emergency department waiting room. He is pulseless and apneic. The cardiac monitor displays chaotic, irregular electrical activity with no discernible waveforms. The patient has no history of trauma.
What is the most appropriate next step in management?
Immediate defibrillation
The patient is in ventricular fibrillation, which is a shockable rhythm; the most critical step is immediate defibrillation to restore organized cardiac activity.
Full handout
High yield triage
Etiology / Epidemiology
Most common cause is ischemic heart disease and myocardial infarction. Often triggered by R-on-T phenomenon.
Clinical Manifestations
Patient is unresponsive, pulseless, and apneic. Sudden cardiac death is the classic presentation.
Diagnosis
ECG shows chaotic, irregular deflections of varying amplitude with no identifiable P, QRS, or T waves.
Treatment
Immediate unsynchronized defibrillation is the priority. Epinephrine is the first-line vasopressor.
Prognosis
Survival depends on time to defibrillation. Every minute delay reduces survival by 7-10%.
Full handout
Epidemiology & Etiology
VF is the most frequent rhythm in sudden cardiac death, primarily affecting patients with coronary artery disease. Other triggers include electrolyte imbalances (hypokalemia/hypomagnesemia), long QT syndrome, and hypertrophic cardiomyopathy. It is the terminal event in many patients with structural heart disease.
Pertinent Anatomy
The electrical instability originates in the ventricular myocardium. Disorganized electrical activity prevents effective ventricular contraction, leading to immediate cessation of cardiac output.
Pathophysiology
VF results from multiple re-entrant wavelets circulating through the ventricles. This leads to hemodynamic collapse as the heart ceases to function as a pump. Without intervention, the myocardium becomes ischemic and metabolic acidosis ensues.
Clinical Manifestations
The patient presents with sudden loss of consciousness and absence of a palpable pulse. Agonal breathing may be present initially. Do not delay defibrillation to check for a pulse; immediate recognition of unresponsiveness is the clinical trigger for the ACLS algorithm.
Diagnosis
The ECG is the diagnostic gold standard, demonstrating coarse or fine irregular undulations. There is a complete absence of organized electrical activity. No other diagnostic tests are indicated in the acute setting.
Treatment
Initiate high-quality CPR immediately while preparing for unsynchronized defibrillation (200J biphasic). If VF persists after shocks, administer epinephrine every 3-5 minutes. Do not use synchronized cardioversion as the machine will fail to detect an R-wave. Consider amiodarone or lidocaine for refractory VF.
Prognosis
Prognosis is poor without immediate bystander CPR and rapid defibrillation. Survivors are at high risk for recurrence and often require an implantable cardioverter-defibrillator (ICD) for secondary prevention.
Differential Diagnosis
Pulseless Electrical Activity: organized rhythm present but no pulse
Asystole: flatline on ECG, non-shockable
Ventricular Tachycardia: wide-complex tachycardia, may be pulseless
Torsades de Pointes: polymorphic VT associated with prolonged QT
Severe Hypovolemia: can mimic pulselessness, check for reversible causes